China (Mainland)
Diamondsupplier
(4R,6R)-tert-Butyl-6-(2-aMinoethyl)-2,2-diMethyl-1,3-dioxane-4-acetate manufacture CAS NO.125995-13-3
- FOB Price: USD: 200.00-200.00 /Metric Ton Get Latest Price
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T,
- Available Specifications:
Pharm Grade(1-1.1)Metric Ton
- Product Details
Keywords
- (4R,6R)-tert-Butyl-6-(2-aMinoethyl)-2,2-diMethyl-1,3-dioxane-4-acetate suppiler
- (4R,6R)-tert-Butyl-6-(2-aMinoethyl)-2,2-diMethyl-1,3-dioxane-4-acetate
- high quality (4R,6R)-tert-Butyl-6-(2-aMinoethyl)-2,2-diMethyl-1,3-dioxane-4-acetate
Quick Details
- ProName: (4R,6R)-tert-Butyl-6-(2-aMinoethyl)-2,...
- CasNo: 125995-13-3
- Molecular Formula: C14H27NO4
- Appearance: light yellow-blue liquid
- Application: Atorvastatin calcium intermediates
- DeliveryTime: 15days to 1 mounth
- PackAge: According to client's requirements
- Port: SHANGHAI,CHINA
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 98.00%
- Storage: keep sealed and keep from direct light
- Transportation: According to client's requirements
- LimitNum: 10 Gram
- Moisture Content: send with COA
- Impurity: send with COA
Superiority
Product Name:Atorvastatin intermediates Ats-9
Synonym:(4R,Cis)-1,1-dimethylethyl6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-Acetate;(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate;tert-butyl ((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-yl)acetate;
Cas No:125995-13-3
Molecular Formula:C14H27NO4
Molecular Weight:273.37
|
Test Item |
Standard |
| Appearance | light yellow-blue liquid |
|
Methanol |
Less than 3.0% |
| Assay GC (%) | More than 98.0% |
| Water (%) | Less than 0.5 |
| Packing Size | Less than 1Kg : Plastic Bottles |
| Less than 20 Kg : Standard Plastic buckets for export | |
| More than 20 Kg : Standard Plastic buckets for export | |
| Note | Liquid |
Details
Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization. Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.
It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.